Africa: IP in Africa: A little different

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Africa: IP in Africa: A little different

An article that recently appeared in the South African news publication Daily Maverick, Intellectual property for the 21st century economy, reminds us that, notwithstanding the increasing homogenisation of IP laws, parts of the developing world are yet to be totally convinced that IP is the best way of ensuring innovation and progress.

The article was written by renowned economist Joseph Stiglitz. He comes right to the point when he says this: 'Developing countries are increasingly pushing back against the intellectual property regime foisted on them by advanced economies over the last 30 years… they are right to do so because what matters is not only the production of knowledge, but also that it is used in ways that put the health and well-being of people ahead of corporate profits.'

According to Stiglitz, the pushback is being led by South Africa, India and Brazil, and the focus is medicines. Although South Africa has in the past felt the 'full legal might of the global pharmaceutical industry', it is in the process of finalising an IP policy that expands access to medicines. The South African government 'is right, and other developing and emerging economies should follow in its footsteps.'

Stiglitz is critical of IP: it was wrong to impose a 'one-size-fits-all' policy; the standards imposed by the developed world are not designed to maximise progress and innovation, but rather corporate profits; the institutions and laws protecting knowledge are increasingly inadequate to govern global economic activity, and poorly suited to the needs of developing countries; patents may encourage research, but the sheer number of patents now stifles innovation; much of the research that is taking place is aimed at extending protection rather than creating new products. The IP regime has, says Stiglitz, erected barriers to the use of knowledge, and this is not sustainable.

Stiglitz says that the 21st century economy will differ from that of the 20th century in two major ways – the economic weight of countries like South Africa, Brazil and India will increase, and the economy of ideas, knowledge and information will become increasingly important. Developing countries should be looking at alternatives to patents for financing research, including centralised bodies like national health institutes, tax credits and prizes.

IP owners in the developed world, as well as their advisors, would do well to bear these philosophical differences in mind

Wayne Meiring


Spoor & Fisher Jersey Africa House, Castle Street St Helier, Jersey JE4 9TW Channel Islands Tel: +44 1534 838000 Fax: +44 1534 838001

info@spoor.co.uk

www.spoor.com

more from across site and SHARED ros bottom lb

More from across our site

Andrea Stone explains how her in-house experience gives her a unique perspective, and why Ballard Spahr’s combination with Lane Powell made it an ideal time to join
The pair had been fighting in multiple jurisdictions but have agreed to settle all litigation
Law firms may try to relate PTAB briefs to broader economic concerns in response to the USPTO’s latest guidance
IP Inclusive’s 10-year celebration provides reasons to be positive in the face of troubling attacks against DEI initiatives
Microsoft allegedly uses the HEVC technology in a range of products and offers an extension as an add-on
A group of five lawyers who joined Cleary Gottlieb say they want to help expand the firm’s IP litigation practice
As we build up to another busy year for the IP STARS rankings and our Managing IP Awards, we assess some of the major IP firms and trends in Germany
Florina Firaru discusses making new connections, the art of flower arranging, and the biggest misconception about IP
The firm, which appointed three IP partners from A&O Shearman, wants to develop a tier one practice in Europe
The England and Wales appeals court handed down its judgment just seven working days after hearing the trademark dispute involving pharma company Merck
Gift this article